Robert Crane - 08 Feb 2022 Form 3 Insider Report for Axcella Health Inc.

Role
Chief Financial Officer
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Feb 2022
Net transactions value
$0
Form type
3
Filing time
28 Feb 2022, 15:25:45 UTC
Next filing
18 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXLA Stock Option (Right to Buy) 08 Feb 2022 Common Stock 200,000 $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in twelve equal quarterly installments thereafter, subject to subject to Reporting Person's continued service on each such vesting date

Remarks:

Exhibit 24 - Power of Attorney